Page 1435 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

32. Sterns RH, et al. Neurologic sequelae after treatment of severe potassium and free fatty acids without its effect on glucose.
hyponatremia: a multicenter perspective. J Am Soc Nephrol. J Clin Invest. 1964;43:950-962.
1994;4(8):1522-1530. 55. Squires RD, Huth EJ. Experimental potassium depletion in
33. Verbalis J, et al. Hyponatremia treatment guidelines 2007: expert normal human subjects. I. Relation of ionic intakes to the
panel recommendations. Am J Med. 2007;120(11 suppl 1):21. renal conservation of potassium. J Clin Invest. 1959;38(7):
34. Sterns R, Nigwekar S, Hix J. The treatment of hyponatremia. 1134-1148.
Semin Nephrol. 2009;29(3):282-299. 56. Rabelink TJ, et al. Early and late adjustment to potassium load-
35. Kamel KS, Bear RA. Treatment of hyponatremia: a quantitative ing in humans. Kidney Int. 1990;38(5):942-947.
analysis. Am J Kidney Dis. 1993;21(4):439-443. 57. Giebisch G, Wang W. Potassium transport: from clearance to
36. Rose BD. New approach to disturbances in the plasma sodium channels and pumps. Kidney Int. 1996;49(6):1624-1631.
concentration. Am J Med. 1986;81(6):1033-1040. 58. Halperin ML, Kamel KS. Potassium. Lancet. 1998;352(9122):
37. Greenberg A, Verbalis J. Vasopressin receptor antagonists. 135-140.
Kidney Int. 2006;69(12):2124-2130. 59. Sansom S, Muto S, Giebisch G. Na-dependent effects of DOCA
38. Jovanovich AJ, Berl T. Where vaptans do and do not fit in the on cellular transport properties of CCDs from ADX rabbits. Am
treatment of hyponatremia. Kidney Int. 2013;83(4):563-567. J Physiol. 1987;253(4, pt 2):F753-F759.
39. Schrier RW, et al. Tolvaptan, a selective oral vasopressin 60. Morgan DB, Young RM. Acute transient hypokalaemia: new
V2-receptor antagonist, for hyponatremia. N Engl J Med. interpretation of a common event. Lancet. 1982;2(8301):
2006;355(20):2099-2112. 751-752.
40. Berl T, et al. Oral tolvaptan is safe and effective in chronic hypo- 61. Gallen I, et al. On the mechanism of the effects of potassium
natremia. J Am Soc Nephrol. 2010;21(4):705-712. restriction on blood pressure and renal sodium retention. Am J
41. Soupart A, et al. Successful long-term treatment of hyponatre- Kidney Dis. 1998. 31(1):19-27.
mia in syndrome of inappropriate antidiuretic hormone secre- 62. Greenfeld D, et al. Hypokalemia in outpatients with eating dis-
tion with satavaptan (SR121463B), an orally active nonpeptide orders. Am J Psychiatry. 1995;152(1):60-63.
vasopressin V2-receptor antagonist. Clin J Am Soc Nephrol.
2006;1(6):1154-1160. 63. Coma-Canella I. Changes in plasma potassium during the
dobutamine stress test. Int J Cardiol. 1991;33(1):55-59.
42. http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety
AlertsforHumanMedicalProducts/ucm350185.htm. Accessed 64. Kunin AS, Surawicz B, Sims EA. Decrease in serum potassium
July, 2013. concentrations and appearance of cardiac arrhythmias during
43. Lampl C, Yazdi K. Central pontine myelinolysis. Eur Neurol. infusion of potassium with glucose in potassium-depleted
patients. N Engl J Med. 1962;266:228-233.
2002;47(1):3-10.
44. Ayus JC, Krothapalli RK, Arieff AI. Treatment of symptomatic 65. Crook MA, Hally V, Panteli JV. The importance of the refeeding
hyponatremia and its relation to brain damage. A prospective syndrome. Nutrition. 2001;17(7-8):632-637.
study. N Engl J Med. 1987;317(19):1190-1195. 66. Swan RC, AD, Seijs M, Pitts RF. Distribution of sodium
bicarbonate infused into nephrectomised dogs. J Clin Invest.
45. Soupart A, et al. Reinduction of hyponatremia improves sur-
vival in rats with myelinolysis-related neurologic symptoms. 1975(34):1795-1801.
J Neuropathol Exp Neurol. 1996;55(5):594-601. 67. Matthews E, et al. Acetazolamide efficacy in hypokalemic peri-
46. Sterns RH, Hix JK, Silver S. Treatment of hyponatremia. Curr odic paralysis and the predictive role of genotype. Neurology.
Opin Nephrol Hypertens. 2010;19(5):493-498. 2011;77(22):1960-1964.
47. Soupart A, Ngassa M, Decaux G. Therapeutic relowering of the 68. Johnsen T. Trial of the prophylactic effect of diazoxide in the
serum sodium in a patient after excessive correction of hypona- treatment of familial periodic hypokalemia. Acta Neurol Scand.
tremia. Clin Nephrol. 1999;51(6):383-386. 1977;56(6):525-532.
48. Oya S, et al. Reinduction of hyponatremia to treat central 69. Ko GT, et al. Thyrotoxic periodic paralysis in a Chinese popula-
pontine myelinolysis. Neurology. 2001;57(10):1931-1932. tion. QJM. 1996;89(6):463-468.
49. Agarwal R, Afzalpurkar R, Fordtran JS. Pathophysiology of 70. Kelepouris E, Kasama R, Agus ZS. Effects of intracellular mag-
potassium absorption and secretion by the human intestine. nesium on calcium, potassium and chloride channels. Miner
Gastroenterology. 1994;107(2):548-571. Electrolyte Metab. 1993;19(4-5):277-281.
50. Cummings JH, et al. Fecal weight, colon cancer risk, and 71. Hammer HF, et al. Studies of osmotic diarrhea induced in nor-
dietary intake of nonstarch polysaccharides (dietary fiber). mal subjects by ingestion of polyethylene glycol and lactulose.
Gastroenterology. 1992;103(6):1783-1789. J Clin Invest. 1989;84(4):1056-1062.
51. Bjork JT, SK, Wood CM. The composition of ‘free’ stool water. 72. Holland OB, Nixon JV, Kuhnert L. Diuretic-induced ventricular
Gastroenterology. 1976(70). ectopic activity. Am J Med. 1981;70(4):762-768.
52. Deitrick JE, WG, Shorr E. Effects of immobilization upon vari- 73. Wahr JA, et al. Preoperative serum potassium levels and peri-
ous metabolic ans physiologic functions in normal men. Am J operative outcomes in cardiac surgery patients. Multicenter
Med. 1948;4(3). Study of Perioperative Ischemia Research Group. JAMA.
53. Williams ME, et al. Catecholamine modulation of rapid potas- 1999;281(23):2203-2210.
sium shifts during exercise. N Engl J Med. 1985;312(13):823-827. 74. Nordrehaug JE. Malignant arrhythmias in relation to serum
54. Zierler KL, Rabinowitz D. Effect of very small concentrations potassium values in patients with an acute myocardial infarc-
of insulin on forearm metabolism. Persistence of its action on tion. Acta Med Scand Suppl. 1981;647:101-107.

Section08-O-Ref.indd 2 12/10/2014 6:08:09 PM